Related Experiment Video
Updated: Dec 13, 2025

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential
1Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Insights
Clonal hematopoiesis of indeterminate potential (CHIP) mutations in aging individuals increase risks for hematological cancers and cardiovascular disease (CVD). This review explores how CHIP impacts stem cells and various blood cell types to influence these diseases.
Area of Science:
- Hematology
- Genetics
- Cardiovascular Science
Background:
- Clonal hematopoiesis of indeterminate potential (CHIP) involves somatic mutations in aging individuals.
- CHIP increases the risk of hematological malignancies and cardiovascular disease (CVD).
- Mutations in hematopoietic stem and progenitor cells (HSPCs) may affect diverse blood lineages involved in CVD pathogenesis.
Purpose of the Study:
- To review mechanisms linking CHIP-associated mutations to CVD.
- To explore potential pathogenic links between CHIP-associated CVD and hematological malignancy.
- To highlight the role of stem cell biology in CHIP-related diseases.
Main Methods:
- This is a review article, synthesizing existing research.
- Discussion of proposed pathogenic mechanisms.
- Analysis of stem cell biology's role.
Main Results:
- CHIP mutations can affect multiple hematopoietic lineages.
- Inflammation is a potential mechanism linking CHIP, CVD, and hematological malignancy.
- The relationship between CHIP-associated CVD and hematological malignancy suggests a common disease spectrum.
Conclusions:
- CHIP mutations contribute to both CVD and hematological malignancy.
- Understanding stem cell alterations is crucial for CHIP-related disease pathogenesis and treatment.
- Further research is needed to elucidate the common pathways linking CHIP to CVD and hematological malignancy.
Abstract:
Characterized by the expansion of somatic mutations in the hematopoietic lineages of aging individuals, clonal hematopoiesis of indeterminate potential (CHIP) is a common condition that increases the risk of developing hematological malignancies and cardiovascular disease (CVD). The presence of CHIP-associated mutations in hematopoietic stem and progenitor cells (HSPCs) suggests that these mutations may alter the functions of the diverse hematopoietic lineages, many of which influence the pathogenesis of CVD. Inflammation may be a potential pathogenic mechanism, linking both CVD and hematological malignancy. However, it remains unknown whether CHIP-associated CVD and hematological malignancy are features of a common disease spectrum. The contributions of CHIP-associated mutations to both CVD and hematological malignancy underscore the importance of stem cell biology in pathogenesis and treatment. This review discusses possible mechanisms underlying the contributions of multiple hematopoietic lineages to CHIP-associated CVD and the putative pathogenic links between CHIP-associated CVD and hematological malignancy.
More Related Videos
08:14Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
09:32Clonal Analysis of Embryonic Hematopoietic Stem Cell Precursors Using Single Cell Index Sorting Combined with Endothelial Cell Niche Co-culture
Published on: May 8, 2018
Related Concept Videos
Hematopoiesis
Regulation of Hematopoietic Stem Cells
Multipotency of Hematopoietic Stem Cells
Lineage Commitment
Production of Formed Elements
Most HSCs commit to...
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...